ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Share-based Compensation of $574451.0 for Q1 2026, up 591.73% year-over-year from $83046.0 in Q1 2025, and up 4360.72% quarter-over-quarter from $12878.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Share-based Compensation (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Share-based Compensation data on file, last reported at $574451.0 in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $574451.0, up 591.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $731624.0 (up 116.79% YoY), and the FY2025 annual result was $329409.0, down 42.4% from the prior year.
- Share-based Compensation grew to $574451.0 in Q1 2026 per NDRA's latest filing, from $12878.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $909069.0 in Q3 2022 and troughed at -$288537.0 in Q2 2022.
- A 5-year average of $210756.6 and a median of $237279.0 in 2023 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2026: Share-based Compensation slumped 175.32% in 2022, then jumped 591.73% in 2026.
- A 5-year view of Share-based Compensation shows it stood at $290769.0 in 2022, then slipped by 13.83% to $250557.0 in 2023, then plunged by 58.22% to $104684.0 in 2024, then tumbled by 87.7% to $12878.0 in 2025, then soared by 4360.72% to $574451.0 in 2026.
- Business Quant data shows NDRA's Share-based Compensation at $574451.0 in Q1 2026, $12878.0 in Q4 2025, and $104765.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 20.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 83.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 58.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 16.34 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 32.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 65.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 95.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 60.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 5.47 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | 574,451.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 574,451.00 |
| Mar 31, 2026 | 574,451.00 |
| Dec 31, 2025 | 12,878.00 |
| Dec 31, 2025 | 12,878.00 |
| Sep 30, 2025 | 104,765.00 |
| Sep 30, 2025 | 104,765.00 |
| Jun 30, 2025 | 39,530.00 |
| Jun 30, 2025 | 39,530.00 |
| Mar 31, 2025 | 83,046.00 |
| Mar 31, 2025 | 83,046.00 |
| Dec 31, 2024 | 104,684.00 |
| Dec 31, 2024 | 104,684.00 |
| Sep 30, 2024 | -36,847.00 |
| Sep 30, 2024 | -36,847.00 |
| Jun 30, 2024 | 186,590.00 |
| Jun 30, 2024 | 186,590.00 |
| Mar 31, 2024 | 317,497.00 |
| Mar 31, 2024 | 317,497.00 |
| Dec 31, 2023 | 250,557.00 |
| Dec 31, 2023 | 250,557.00 |